Our Partners for 2025

Expertise Partners:

wuxi

WuXi AppTec

WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable the pharmaceutical and healthcare industry around the world to advance discoveries and deliver groundbreaking treatments to patients. WuXi AppTec’s integrated, end-to-end services include chemistry drug CRDMO (Contract Research, Development and Manufacturing Organization), biology discovery, preclinical testing and clinical research services, and cell and gene therapies CTDMO (Contract Testing, Development and Manufacturing Organization), helping customers improve the productivity of advancing healthcare products through cost-effective and efficient solutions.

www.wuxiapptec.com

MM_stacked-logo-w-tagline_transparent

Montana Molecular

Montana Molecular's unique products and services provide valuable insights that accelerate drug discovery and reduce late stage failures. Our GPCR discovery tools combine fluorescent biosensors, controllable gene expression and kinetic signaling analysis in living cells to reliably profile and prioritize lead compounds. Our expert team is committed to producing the highest quality data and products for the development of better treatments for disease.

Exhibition Partners:

Logo_Vazyme

Vazyme

Vazyme is a global technology and service provider dedicated to the design, manufacture, and application of bioactive proteins. With outstanding product quality and extensive supply chain expertise, we are driving innovation in T7 polymerases to meet diverse RNA synthesis needs, and are able to self-develop and produce dsRNA residue detection kits. Our GMP grade mRNA tool enzymes and quality control kits ensure safety and efficacy, accelerating mRNA vaccine/drug R&D and advancing projects to clinical trials. 

www.vazymebiotech.com

2017_PromegaLogo_Sol (2)

Promega

Promega provides innovative bioassays and analytical tools to accelerate GPCR-targeted drug discovery. Our portfolio includes functional assays for receptor activation and internalization, cAMP and other second messenger assays for signaling studies, and luminescent technologies for ligand binding and pathway analysis. Whether optimizing GPCR screening, characterizing drug candidates, or developing custom bioassays, Promega delivers scalable, high-quality solutions to advance small-molecule and biologics therapeutics.

Connect with us to learn more.

www.promega.com

GeneTex logo_300dpi_L(1)

GeneTex

GeneTex is a multinational antibody manufacturer with over 25 years of experience generating antibodies for biomedical research. In 2020, the company implemented a high-throughput recombinant monoclonal antibody production platform combined with enhanced validation strategies. Using this approach, GeneTex is focused on creating a best-in-class collection of antibodies targeting the approximately 350 human non-sensory GPCRs with the goal of advancing GPCR research and drug discovery.

www.genetex.com

Event Partner:

Nxera Master Logo RGB Black

Nxera

Nxera Pharma (formerly Sosei Heptares) is a technology powered biopharma company, in pursuit of medicines to improve the lives of patients with unmet needs in Japan and globally. In addition to several products being commercialized in Japan, we’re advancing an extensive pipeline of over 30 active programs from discovery through to late clinical stage internally and in partnership with leading pharma and biotech companies. This pipeline is focused on addressing major unmet needs in some of the fastest-growing areas of medicine across neurology, GI and immunology, metabolic disorders and rare diseases, leveraging the power of our unique and industry leading GPCR-targeted SBDD NxWave™ platform.
PARTNER WITH US